StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2021 - 01 - 14
1
2021 - 01 - 13
1
2021 - 01 - 06
1
2020 - 12 - 07
1
Sector
Health technology
4
Tags
Acquisition
4
Application
4
Approval
3
Awards
9
Biotech
4
Calendar of events
9
Cancer
5
Collaboration
5
Commercialization
6
Company announcement
13
Conference
9
Contract
4
Covid
9
Covid-19
5
Designation
7
Directors and officers
5
Disease
6
Drug
5
Earnings releases and operating results
3
Electronics
3
Energy
8
Enroll
3
Europe
3
Ev
7
Expansion
5
Fda
6
Financial results
11
Food
3
Grant
4
Granted
4
Growth
5
Health
7
Heart
3
India
3
Injection
3
License
4
Life science
7
Liver
5
N/a
343
Nasdaq
11
Offering
24
Order
9
Partnership
10
Pharma
7
Phase 2
8
Phase 3
10
Positive
9
Potential
4
Presentation
5
Program
6
Publication
6
Research
14
Results
27
Sales
4
System
4
Test
6
Therapy
5
Treatment
11
Trial
10
Vaccine
5
Entities
Arcutis biotherapeutics, inc.
2
Pds biotechnology corporation
1
Vaxcyte, inc.
1
Symbols
ARQT
2
PCVX
1
PDSB
1
Exchanges
Nasdaq
4
Crawled Date
2021 - 01 - 14
1
2021 - 01 - 13
1
2021 - 01 - 06
1
2020 - 12 - 07
1
Crawled Time
00:00
21
00:01
2
00:20
4
01:00
24
02:00
9
02:09
1
03:00
11
03:10
2
03:11
1
04:00
10
04:20
12
05:00
12
06:00
18
07:00
21
08:00
22
08:20
1
09:00
35
09:07
2
10:00
42
10:16
1
11:00
83
11:01
1
12:00
181
12:01
3
12:03
2
12:06
1
12:07
1
12:11
1
12:15
14
12:20
55
12:30
31
13:00
145
13:03
2
13:15
17
13:20
42
13:30
28
13:32
2
14:00
88
14:01
4
14:02
2
14:03
2
14:08
2
14:15
8
14:20
15
14:30
22
15:00
70
15:01
2
15:15
3
15:20
9
15:30
13
16:00
49
16:20
21
17:00
39
18:00
37
19:00
40
20:00
57
20:20
8
21:00
53
22:00
47
23:00
41
Source
www.globenewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Potential
crawled time :
14:01
save search
PDS Biotech Releases White Paper Detailing the Potential of the Versamune® Platform in Overcoming a Major Limitation of Immuno-Oncology
Published:
2021-01-14
(Crawled : 14:01)
- globenewswire.com
PDSB
|
$2.99
13.04%
11.54%
660K
|
Health Technology
|
15.0%
|
O:
1.15%
H:
8.37%
C:
4.94%
biotech
potential
Arcutis Initiates Pivotal Phase 3 Clinical Trials Evaluating Topical Roflumilast Cream (ARQ-151) as a Potential Treatment for Atopic Dermatitis
Published:
2021-01-13
(Crawled : 14:01)
- globenewswire.com
ARQT
|
$8.94
-1.76%
-1.9%
1M
|
Health Technology
|
-67.28%
|
O:
-0.92%
H:
4.67%
C:
0.26%
dermatitis
phase 3
trial
treatment
potential
atopic dermatitis
Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections
Published:
2021-01-06
(Crawled : 14:01)
- globenewswire.com
PCVX
|
$61.6
1.27%
1.24%
630K
|
Health Technology
|
125.15%
|
O:
7.13%
H:
5.34%
C:
-0.51%
vaccine
potential
injection
preclinical
pre-clinical
designation
infections
Arcutis Announces Last Patient Completes Final Study Visit in DERMIS-1 and DERMIS-2 Pivotal Phase 3 Clinical Trials Evaluating ARQ-151 (Topical Roflumilast Cream) as a Potential Treatment for Plaque Psoriasis
Published:
2020-12-07
(Crawled : 14:01)
- globenewswire.com
ARQT
|
$8.94
-1.76%
-1.9%
1M
|
Health Technology
|
-65.63%
|
O:
0.88%
H:
2.25%
C:
1.03%
phase 3
trial
potential
psoriasis
plague
Gainers vs Losers
73%
27%
Top 10 Gainers
MTTR
|
News
M
|
$4.8
175.86%
63.6%
71M
|
AGBA
|
$2.5
100.0%
56.6%
200M
|
Finance
MLEC
|
$2.47
76.43%
42.62%
78M
|
n/a
NUWE
|
$0.334
29.96%
40.99%
2.5M
|
Manufacturing
EDBL
|
News
|
$6.26
66.49%
40.13%
16M
|
ATGL
|
$2.86
46.25%
32.8%
180K
|
VIVK
|
$1.43
33.65%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.7M
|
SDIG
A
|
$3.64
35.32%
26.0%
990K
|
PROK
|
$2.72
33.33%
24.58%
2.6M
|
Your saved searches
Save your searches and get alerts when important news are released.